VG Life Sciences Inc. (VGLS)

[losersellsearly]

No problemo that .07 will be looking like a cheap entry point soon.

VRAL is one of the few biotechs that has been doing it right - complete transparency, squashed rumors last year, only releases the real deal info. Note the time it has taken for them to build the solid science portfolio...now the patient are going to be rewarded.

SAN MARINO, Calif., Feb. 11 /PRNewswire-FirstCall/ -- (Pink Sheets: VRAL) -- Our mission is to bring new drug compounds to the marketplace. And we've never been in a stronger position to deliver on that promise. We've built the solid foundation needed to take drug therapies from the laboratory to the marketplace. After years in development, we believe several of our most promising compounds are moving closer to clinical trials.

During 2009, Viral Genetics made significant strides on two fronts -- scientific and financial. Our drug compounds seem to be showing great potential. Additionally, we've built an infrastructure that enables us to use money wisely. We have retired nearly all of our external debt, enabling us to leverage any additional funding to advance new drug therapies -- rather than making interest payments to creditors.